Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.66 |
| ▸ | BCR | P11274 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.63 |
| ▸ | TYR | P14679 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | CCR3 | P51677 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3504047 | 1.00 | ABL1 (0.66) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL1245762 | 1.00 | ABL1 (0.66) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL30491036 | 0.92 | TYR (0.65) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL10602315 | 0.92 | TYR (0.65) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL2119058 | 0.92 | TYR (0.65) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL21852875 | 0.92 | TYR (0.65) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL21841319 | 0.90 | TYR (0.58) | ABL1BCRCYP3A4CYP2B6TYR | |
| SCHEMBL16372856 | 0.89 | ABL1 (0.80) | ABL1BCRCYP3A4CYP2B6CYP1A2 | |
| SCHEMBL17843663 | 0.89 | ABL1 (0.80) | ABL1BCRCYP3A4CYP2B6CYP1A2 | |
| SCHEMBL23829549 | 0.88 | PTGS1 (0.57) | ABL1BCRCYP3A4CYP2B6TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1646 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056926-A | Probiotic composition containing melatonin and application of composition in sleep | 南京北极光生物科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-3148345-B1 | METHOD FOR REFINING LIPID PHASES, AND USE | DREI LILIEN PVG GMBH&CO KG (DE) | 2026-04-29 | — | — | EP | claimed |
| US-12611392-B2 | Mitochondria-targeting antioxidants | GIVAUDAN SA (CH) | 2026-04-28 | — | — | US | claimed |
| CN-121577798-A | Method for simultaneously measuring contents of 5 ingredients in medicinal and edible beverage and application thereof | 河南中医药大学第一附属医院 | 2026-02-27 | — | — | CN | claimed |
| EP-4249494-B1 | A DRUG COMPRISING A RADICAL GENERATING CATALYST | ACENET INC (JP) | 2025-07-16 | — | — | EP | claimed |
| EP-4583708-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2025-07-16 | — | — | EP | claimed |
| EP-4054552-B1 | MITROCHONDRIA-TARGETING ANTIOXIDANTS | GIVAUDAN SA (CH) | 2025-07-02 | — | — | EP | claimed |
| CN-120091758-A | Arthropod control composition | 弗门尼舍有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120052544-A | Sinapine-loaded dopamine terminal composite gel and application thereof | 扬州大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120037294-A | Traditional Chinese medicine plaster based on meridian point targeted drug delivery and preparation method and application thereof | 沈军伟 | 2025-05-27 | — | — | CN | claimed |
| WO-1999037786-A2 | METHODS AND COMPOSITIONS FOR MODIFYING LEVELS OF SECONDARY METABOLIC COMPOUNDS IN PLANTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1999-07-29 | — | — | WO | claimed |
| CN-1189365-A | Medicine for preventing Aids virus, treponema pallidum, neisseria gonorrhoeae and trichomonad | LEI XUEJUN (CN) | 1998-08-05 | — | — | CN | claimed |
| EP-0831715-A1 | METHODS OF TREATING PLANT MATERIALS WITH HYDROLYTIC ENZYMES | ZYLEPSIS LIMITED (GB) | 1998-04-01 | — | — | EP | claimed |
| EP-0650365-B1 | BIOCIDAL COMPOSITION CONTAINING MUSTARD SEED PLANT EXTRACT | ALATESE LTD (GB) | 1997-05-14 | — | — | EP | claimed |
| WO-1996039859-A1 | METHODS OF TREATING PLANT MATERIALS WITH HYDROLYTIC ENZYMES | ZYLEPSIS LIMITED (GB) | 1996-12-19 | — | — | WO | claimed |
| EP-0650365-A1 | BIOCIDAL COMPOSITION CONTAINING MUSTARD SEED PLANT EXTRACT. | CONCANNON PETER (GB) | 1995-05-03 | — | — | EP | claimed |
| EP-0364952-B1 | Determining seed viability | CORNELL RES FOUNDATION INC (US) | 1994-04-20 | — | — | EP | claimed |
| WO-1994001121-A1 | BIOCIDAL COMPOSITION CONTAINING MUSTARD SEED PLANT EXTRACT | CONCANNON PETER (GB) | 1994-01-20 | — | — | WO | claimed |
| US-4975364-A | Detecting sinapine likage | CORNELL RESEARCH FOUNDATION, INC. (US) | 1990-12-04 | — | — | US | claimed |
| EP-0364952-A2 | Determining seed viability | CORNELL RESEARCH FOUNDATION, INC. (US) | 1990-04-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611392-B2 | Mitochondria-targeting antioxidants | CPT1B, CPT2, SLC25A20 | ABL1 3992/4885BCR 3569/4885CYP3A4 1955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.